|

Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation

RECRUITINGSponsored by Peking University Third Hospital
Actively Recruiting
SponsorPeking University Third Hospital
Started2023-01-01
Est. completion2024-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05638841

Summary

In this study, the continuous inclusion of atrial fibrillation patients treated by catheter ablation in the Department of Cardiology, Peking University Third Hospital, through the collection of clinical data and outpatient follow-up, to explore the risk factors of atrial fibrillation recurrence after catheter ablation and the influencing factors of major clinical events in atrial fibrillation patients, and further guide the management mode of atrial fibrillation patients.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* 1\) Age \> 18
* 2\) ECG or holter electrocardiogram confirmed atrial fibrillation

Exclusion Criteria:

* 1\) Hematological diseases, autoimmune diseases and malignant tumors
* 2\) Immobility caused by hemiplegia or severe trauma
* 3\) The expected survival time is less than 2 years
* 4\) Poor compliance and high risk of expected loss of follow-up
* 5\) Disorders of consciousness or Alzheimer's disease

Conditions2

Atrial FibrillationHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.